Arcturus Therapeutics Holdings Inc.
NASDAQ: ARCT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Joseph E. Payne
- Employees
- 174
- Headquarters
- San Diego, United States
- IPO year
- 2013
- Market cap
- $199.2M
- Website
- https://arcturusrx.com
Loading ARCT…
Loading profile data…Frequently asked questions about ARCT
What does Arcturus Therapeutics Holdings Inc. (ARCT) do?
Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respiratory conditions across the United States. Its notable development programs encompass LUNAR-OTC, designed for ornithine transcarbamylase (OTC) defic...
Where does ARCT trade?
Arcturus Therapeutics Holdings Inc. (ARCT) trades on the NASDAQ Global Market.
What sector is ARCT in?
Arcturus Therapeutics Holdings Inc. (ARCT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Arcturus Therapeutics Holdings Inc.?
Joseph E. Payne is the chief executive officer of Arcturus Therapeutics Holdings Inc. (ARCT).
Where is Arcturus Therapeutics Holdings Inc. headquartered?
Arcturus Therapeutics Holdings Inc. is headquartered in United States.
Does ARCT pay a dividend?
Arcturus Therapeutics Holdings Inc. (ARCT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ARCT go public?
Arcturus Therapeutics Holdings Inc. (ARCT) completed its initial public offering in 2013.